MAES, TAMARA,MASCARO CRUSAT, CRISTINA,ROTLLANT POZO, DAVID
申请号：
CA2987876
公开号：
CA2987876A1
申请日:
2016.06.10
申请国别(地区):
CA
年份:
2016
代理人:
摘要：
Therapy employing LSDl inhibitors, in particular arylcyclopropylamino compounds, and uses thereof to assess target engagement and to follow patient response to treatment, in particular by measuring the expression of the genes S100A8 and S100A9 and in particular in the context of CNS diseases, e.g. Alzheimer's disease, or multiple sclerosis.
